Clinical evidence suggests that the release of chemokines, such as MCP-1, mediates the migration of monocytes from the blood circulation to breast tumors where they become active macrophages, thus contributing to BCa progression [14,15]. This evidence concerns the gene CCL2 and breast neoplasm.